RSCM
RARX
Rock Springs Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-750,000
| Closed | -$35.2M | – | 139 |
|
|
2019
Q4 | $35.2M | Sell |
750,000
-85,000
| -10% | -$3.99M | 1.11% | 28 |
|
|
2019
Q3 | $19.7M | Buy |
835,000
+31,000
| +4% | +$733K | 0.79% | 49 |
|
|
2019
Q2 | $24.2M | Hold |
804,000
| – | – | 0.87% | 42 |
|
|
2019
Q1 | $18M | Buy |
804,000
+54,000
| +7% | +$1.21M | 0.69% | 49 |
|
|
2018
Q4 | $13.7M | Hold |
750,000
| – | – | 0.64% | 51 |
|
|
2018
Q3 | $13.6M | Hold |
750,000
| – | – | 0.49% | 65 |
|
|
2018
Q2 | $7.46M | Buy |
750,000
+150,000
| +25% | +$1.49M | 0.29% | 100 |
|
|
2018
Q1 | $3.19M | Hold |
600,000
| – | – | 0.14% | 130 |
|
|
2017
Q4 | $5.1M | Hold |
600,000
| – | – | 0.23% | 107 |
|
|
2017
Q3 | $8.76M | Hold |
600,000
| – | – | 0.4% | 79 |
|
|
2017
Q2 | $11.2M | Sell |
600,000
-188,959
| -24% | -$3.54M | 0.57% | 60 |
|
|
2017
Q1 | $16.8M | Sell |
788,959
-37,041
| -4% | -$789K | 0.97% | 36 |
|
|
2016
Q4 | $12.5M | Buy |
+826,000
| New | +$12.5M | 0.84% | 40 |
|